Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer

Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer

Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer

Ribociclib Shows Promising Long-Term Benefits in Early Breast Cancer Treatment

IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma

Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma

Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA

Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL

Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia

SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer

IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer

ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer

ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%

Next-Generation Weight Loss Therapeutic Nimacimab Enters Phase 2 Clinical Trial

Zai Lab Advances Psoriasis Treatment with ZL-1102 Topical Therapy in Phase 2 Trial

Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor

Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials

Pfizer Reports Promising Survival Benefits in Vepdegestrant Trial for Breast Cancer

P3 Study Shows Obesity Drug Tirzepatide Reduces Sleep Apnea Severity by Up to 63%

Roche's Phase III Study Promises Effective Ocrevus Injection for Multiple Sclerosis

Gilead and Merck Announce Historic Data for HIV Treatment: A Weekly Pill Shows Promise

Ozempic Reduces Kidney Disease Risk and Cardiac Deaths by 24% in Diabetics

Elicio Therapeutics' Novel Therapy Successfully Targets KRAS-Mutated Tumors

GenePHIT: Bayer and AskBio Launch Pioneering Gene Therapy Trial for Heart Failure

New Era in Schizophrenia Treatment: Lyndra's Weekly Oral Pill Shows Promising Results

Plant-Based Diets for Kidney Health: Lead to 26% Mortality Risk Reduction in CKD

Pfizer Announces Positive Phase 2b Outcomes for Obesity Drug Candidate, Danuglipron

Roche Reports Remarkable Advancement for Inavolisib Combo in Breast Cancer

Everest's Etrasimod Shows Promising Results in P3 Trial for Ulcerative Colitis

Promising Treatment for Dravet Syndrome: Stoke's STK-001 Shows Potential